Genpact
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 109.89% -0.17pp
- Institutions
- 574 +3
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 26 buys · 24 sells
| Name | Role | Stake |
|---|---|---|
| Nallicheri Tyagarajan | Former Director | 0.34% |
| Balkrishan Kalra | Chief Executive Officer | 0.11% |
| Piyush Mehta | Senior VP, Chief HR Officer & Country Manager of India | 0.09% |
| Michael Weiner | Advisor | 0.06% |
| Riju Vashisht | SVP, Chief Growth Officer, Global Business Leader of Enterprise and Partnerships & Alliances | 0.04% |
| Anil Nanduru | Senior VP and Global Business Leader of Consumer, Healthcare & High Tech Software | 0.04% |
| Laura Conigliaro | Independent Director | 0.04% |
| Mark Verdi | Independent Director | 0.04% |
| James Madden | Independent Chairperson | 0.03% |
| CeCelia Morken | Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-09 | Piyush Mehta | Senior VP, Chief HR Officer & Country Manager of India | Derivative Exercise and Sale | -200,000 | $27.70–43.05 |
| 2026-11-08 | Carol Lindstrom | Independent Director | Open Market Disposition | -2,364 | $42.56 |
| 2026-09-13 | Balkrishan Kalra | Chief Executive Officer | Open Market Disposition | -10,000 | $36.79 |
| 2026-09-08 | Sumita Pandit | Senior Vice President | Other Acquisition | +76,713 | -- |
| 2026-08-18 | Anil Nanduru | Senior VP and Global Business Leader of Consumer, Healthcare & High Tech Software | Open Market Disposition | -6,191 | $37.03 |
| 2026-08-13 | Sameer Dewan | Senior VP & Global Business Leader of Financial Services business | Open Market Disposition | -14,972 | $34.10 |
| 2026-08-12 | Michael Weiner | Advisor | Open Market Disposition | -5,900 | $34.04 |
| 2026-08-11 | Anil Nanduru | Senior VP and Global Business Leader of Consumer, Healthcare & High Tech Software | Open Market Disposition | -29,095 | $33.92–33.96 |
| 2026-08-11 | Anil Nanduru | Senior VP and Global Business Leader of Consumer, Healthcare & High Tech Software | Intent to Sell (Form 144) | -11,852 | $33.92 |
| 2026-08-10 | Anil Nanduru | Senior VP and Global Business Leader of Consumer, Healthcare & High Tech Software | Intent to Sell (Form 144) | -17,243 | $33.96 |
| 2026-04-22 | Mark Verdi | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | James Madden | Independent Chairperson | Other Acquisition | +9,999 | -- |
| 2026-04-22 | CeCelia Morken | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Brian Stevens | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | John Hinshaw | Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Laura Conigliaro | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Nicholas Gangestad | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Carol Lindstrom | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Thimaya Subaiya | Director | Other Acquisition | +6,521 | -- |
| 2026-03-09 | Piyush Mehta | Senior VP, Chief HR Officer & Country Manager of India | Sale to Issuer | -5,702 | $38.92 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Genpact discussion 0 comments